Patents by Inventor Maryline Mancini

Maryline Mancini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NUCLEOTIDE VECTOR, COMPOSITION CONTAINING SUCH VECTOR, AND VACCINE FOR IMMUNIZATION AGAINST HEPATITIS
    Publication number: 20110027318
    Abstract: Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis. Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of such gene in muscle cells. The gene may be the S gene of the hepatitis B virus. A nucleotide vector composition when administered to even chronic HBV carriers is capable of breaking T cell tolerance to the surface antigens of hepatitis B virus. A vaccine preparation containing said bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibers.
    Type: Application
    Filed: March 24, 2009
    Publication date: February 3, 2011
    Applicants: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale
    Inventors: Marie-Louise Michel, Maryline Mancini
  • Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
    Patent number: 7732423
    Abstract: Nucleotide composition containing a vector and vaccine for immunization against hepatitis. Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of the gene in muscle cells. The gene may be the S gene of the hepatitis B virus. A nucleotide vector composition when administered to even chronic HBV carriers is capable of breaking T cell tolerance to the surface antigens of hepatitis B virus. A vaccine preparation containing bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibers.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 8, 2010
    Assignees: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale
    Inventors: Marie-Louise Michel, Maryline Mancini
  • Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
    Publication number: 20090093428
    Abstract: Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis. Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of such gene in muscle cells. The gene may be the S gene of the hepatitis B virus. A nucleotide vector composition when administered to even chronic HBV carriers is capable of breaking T cell tolerance to the surface antigens of hepatitis B virus. A vaccine preparation containing said bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibers.
    Type: Application
    Filed: October 30, 2007
    Publication date: April 9, 2009
    Applicants: Institut Pasteur, Institut National de la Sante et de la Recherche Medicale
    Inventors: Marie-Louise Michel, Maryline Mancini
  • Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
    Publication number: 20030083291
    Abstract: Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis. Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of such gene in muscle cells. The gene may be the S gene of the hepatitis B virus. A nucleotide vector composition when administered to even chronic HBV carriers is capable of breaking T cell tolerance to the surface antigens of hepatitis B virus. A vaccine preparation containing said bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibers.
    Type: Application
    Filed: May 10, 2002
    Publication date: May 1, 2003
    Applicant: Institut Pasteur
    Inventors: Marie-Louise Michel, Maryline Mancini
  • Method for immunization against hepatitis B
    Patent number: 6429201
    Abstract: Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis. Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of such gene in muscle cells. The gene may be the S gene of the hepatitis B virus. A nucleotide vector composition when administered to even chronic HBV carriers is capable of breaking T cell tolerance to the surface antigens of hepatitis B virus. A vaccine preparation containing said bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibers.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: August 6, 2002
    Assignees: Institut Pasteur, Institut de la Sante et de la Recherche Medicale
    Inventors: Marie-Louise Michel, Maryline Mancini
  • Method for immunization against hepatitis B
    Patent number: 6133244
    Abstract: Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis. Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of such gene in muscle cells. The gene may be the S gene of the hepatitis B virus. A nucleotide vector composition when administered to even chronic HBV carriers is capable of breaking T cell tolerance to the surface antigens of hepatitis B virus. A vaccine preparation containing said bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibers.
    Type: Grant
    Filed: February 12, 1997
    Date of Patent: October 17, 2000
    Assignees: Institut Pasteur, Institute National de la Sante et la Recherche Medicale
    Inventors: Marie-Louise Michel, Maryline Mancini